Publications & Posters

Research that inspires, data that informs, and knowledge that empowers.

We are proud to contribute to the latest immunology and inflammation research through scientific publications and medical meetings.

May 2024

Transcriptional profiling of primary human-skin derived mast cell activation by various MRGPRX2 agonists and inhibition with EVO756

November 2023

EVO756 is a novel MRGPRX2 antagonist that potently inhibits human mast cell degranulation in response to multiple agonists – a potential treatment for CSU and beyond

November 2023

Role of MRGPRs in substance P signaling, itch, and mast cell activation

We have a range of chronic inflammatory disease programs currently in development.